Results 221 to 230 of about 170,355 (359)
Health impacts and risk assessment of PM<sub>2.5</sub> and PM<sub>10</sub> at Suburban Site in Pathum Thani, Thailand. [PDF]
Rattanaphra D +5 more
europepmc +1 more source
Abstract Quantitative risk assessments of chemicals are routinely performed using in vivo data from rodents; however, there is growing recognition that non‐animal approaches can be human‐relevant alternatives. There is an urgent need to build confidence in non‐animal alternatives given the international support to reduce the use of animals in toxicity ...
Marc A. Beal +14 more
wiley +1 more source
Past Marks: A Case Report of Basal Cell Carcinoma Induced by Arsenic Exposure. [PDF]
Carreira P +4 more
europepmc +1 more source
NICOTINE AND SOME CARCINOGENS IN SPECIAL REFERENCE TO THE HEPATIC DRUG-METABOLIZING ENZYMES
Iwao Yamamoto +3 more
openalex +1 more source
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source
Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. [PDF]
Patel R +15 more
europepmc +1 more source
A Carcinogenic Action of Testosterone, provoking Uterine Tumours in Mice [PDF]
R. Van Nie +2 more
openalex +1 more source
Abstract Regulatory genetic toxicology focuses on DNA damage and subsequent gene mutations. However, genotoxic agents can also affect epigenetic marks, and incorporation of epigenetic data into the regulatory framework may thus enhance the accuracy of risk assessment.
Roger Godschalk +4 more
wiley +1 more source
Brassica Extracts Prevent Benzo(a)pyrene-Induced Transformation by Modulating Reactive Oxygen Species and Autophagy. [PDF]
Montes-Alvarado JB +9 more
europepmc +1 more source

